Insightec, Inc.

Insightec is a medical device manufacturer specializing in incisionless focused ultrasound technology. The company develops and markets Exablate Neuro, an MRI-guided focused ultrasound platform designed for minimally invasive neurosurgical treatment of Essential Tremor and Tremor-dominant Parkinson's Disease. The Exablate Neuro system uses acoustic energy to precisely target and ablate specific areas of the brain (thalamic nucleus) with sub-millimeter precision, guided in real-time by MRI imaging with continuous temperature monitoring. Treatment is typically performed as an outpatient procedure with immediate therapeutic effects and minimal complications. Patients generally return home the same day. The company holds FDA Pre-Market Approval (PMA P150038) for its primary indication and operates globally with headquarters in Israel, US offices in Miami and Dallas, and regional operations in Japan, China, and Europe. Insightec serves neurosurgeons, neurologists, and hospital systems internationally through direct sales and a network of distribution partners. The platform represents an alternative to traditional neurosurgical interventions, offering incision-free, precision-guided treatment with rapid patient recovery.